Article Text

Download PDFPDF
CASE REPORT
Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin’s lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure

Footnotes

  • Not commissioned; externally peer reviewed.

  • Contributors MF and SB drafted the manuscript. SB reviewed the literature. NG created the treatment protocol and critically revised the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Not commissioned; externally peer reviewed.

  • Contributors MF and SB drafted the manuscript. SB reviewed the literature. NG created the treatment protocol and critically revised the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.